Detalhe da pesquisa
1.
Ceftriaxone efficacy for Mycobacterium avium complex lung disease in the hollow fiber and translation to sustained sputum culture conversion in patients.
J Infect Dis;
2023 Nov 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38036299
2.
Nouveau short-course therapy and morphism mapping for clinical pulmonary Mycobacterium kansasii.
Antimicrob Agents Chemother;
95(5)2023 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33558291
3.
Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy development.
J Antimicrob Chemother;
78(4): 953-964, 2023 04 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36794692
4.
Cumulative Fraction of Response for Once- and Twice-Daily Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis.
Antimicrob Agents Chemother;
65(1)2020 12 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33106263
5.
Duration of pretomanid/moxifloxacin/pyrazinamide therapy compared with standard therapy based on time-to-extinction mathematics.
J Antimicrob Chemother;
75(2): 392-399, 2020 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31713607
6.
Minocycline Immunomodulates via Sonic Hedgehog Signaling and Apoptosis and Has Direct Potency Against Drug-Resistant Tuberculosis.
J Infect Dis;
219(6): 975-985, 2019 02 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30597040
7.
Once-a-week tigecycline for the treatment of drug-resistant TB.
J Antimicrob Chemother;
74(6): 1607-1617, 2019 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30820554
8.
Minocycline treatment for pulmonary Mycobacterium avium complex disease based on pharmacokinetics/pharmacodynamics and Bayesian framework mathematical models.
J Antimicrob Chemother;
74(7): 1952-1961, 2019 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31039251
9.
Efficacy Versus Hepatotoxicity of High-dose Rifampin, Pyrazinamide, and Moxifloxacin to Shorten Tuberculosis Therapy Duration: There Is Still Fight in the Old Warriors Yet!
Clin Infect Dis;
67(suppl_3): S359-S364, 2018 11 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30496465
10.
The Sterilizing Effect of Intermittent Tedizolid for Pulmonary Tuberculosis.
Clin Infect Dis;
67(suppl_3): S336-S341, 2018 11 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30496463
11.
Multiparameter Responses to Tedizolid Monotherapy and Moxifloxacin Combination Therapy Models of Children With Intracellular Tuberculosis.
Clin Infect Dis;
67(suppl_3): S342-S348, 2018 11 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30496456
12.
Artificial intelligence-derived 3-Way Concentration-dependent Antagonism of Gatifloxacin, Pyrazinamide, and Rifampicin During Treatment of Pulmonary Tuberculosis.
Clin Infect Dis;
67(suppl_3): S284-S292, 2018 11 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30496458
13.
Transformation Morphisms and Time-to-Extinction Analysis That Map Therapy Duration From Preclinical Models to Patients With Tuberculosis: Translating From Apples to Oranges.
Clin Infect Dis;
67(suppl_3): S349-S358, 2018 11 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30496464
14.
Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis.
Clin Infect Dis;
67(suppl_3): S317-S326, 2018 11 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30496457
15.
Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis.
Clin Infect Dis;
67(suppl_3): S274-S283, 2018 11 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30496459
16.
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis.
Clin Infect Dis;
67(suppl_3): S293-S302, 2018 11 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30496461
17.
d-Cycloserine Pharmacokinetics/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal.
Clin Infect Dis;
67(suppl_3): S308-S316, 2018 11 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30496460
18.
Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis.
Antimicrob Agents Chemother;
62(2)2018 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29180526
19.
Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence.
Antimicrob Agents Chemother;
61(11)2017 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28807911
20.
Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis.
Antimicrob Agents Chemother;
61(8)2017 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28584143